Transplant considerations in a man with von Hippel-Lindau disease with bilateral renal cell carcinoma and a pancreatic neuroendocrine tumour.
Department of Nephrology, Monash University, Clayton, Victoria, Australia.
Khai Gene
KG
Leong
Department of Nephrology, Monash University, Clayton, Victoria, Australia.|Department of Medicine, Monash University, Clayton, Victoria, Australia.
John
J
Kanellis
Department of Nephrology, Monash University, Clayton, Victoria, Australia.|Department of Medicine, Monash University, Clayton, Victoria, Australia.
William R
WR
Mulley
D000328:Adult; D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000235:genetics / Q000601:surgery*; D004252:DNA Mutational Analysis; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000601:surgery*; D016030:Kidney Transplantation; D008297:Male; D009154:Mutation; D060787:Neoplasm Grading; D009367:Neoplasm Staging; D009392:Nephrectomy; D018358:Neuroendocrine Tumors / Q000175:diagnosis / Q000235:genetics / Q000601:surgery*; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000601:surgery*; D018579:Patient Selection; D049268:Positron-Emission Tomography; D012086:Reoperation; D013997:Time Factors; D061665:Time-to-Treatment; D051794:Von Hippel-Lindau Tumor Suppressor Protein / Q000235:genetics; D006623:von Hippel-Lindau Disease / Q000175:diagnosis* / Q000235:genetics
D051794:Von Hippel-Lindau Tumor Suppressor Protein; C497446:VHL protein, human